METHODS OF TREATING UVEAL MELANOMA WITH A PKC INHIBITOR

Title:

METHODS OF TREATING UVEAL MELANOMA WITH A PKC INHIBITOR

Document Type and Number:

WIPO Patent Application WO/2024/044774

Kind Code:

A3

Abstract:

Provided herein is a neoadjuvant therapy and/or adjuvant therapy for the treatment of uveal melanoma, inter alia, ocular tumors in uveal melanoma to reduce the incidence of metastasis and/or enucleation and/or preserving eye function.

More Like This:

WO/2024/042494	SUBSTITUTED PYRROLOTRIAZINES
JP7067804	Immunological biomarkers that predict the clinical effects of cancer immunotherapy
WO/2003/082288	CARBAMIC ACID COMPOUNDS COMPRISING A PIPERAZINE LINKAGE AS HDAC INHIBITORS

Inventors:

JOSHUA ANTHONY M (AU)
MAURER MATTHEW ANTHONY (US)
O'QUIGLEY MICHAEL GABRIEL (US)
HAMBLETON JULIE (US)

Application Number:

PCT/US2023/072953

Publication Date:

April 18, 2024

Filing Date:

August 25, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

IDEAYA BIOSCIENCES INC (US)
ST VINCENTS HOSPITAL SYDNEY LTD (AU)
JOSHUA ANTHONY M (AU)

International Classes:

A61P35/00; A61N5/10; G01N33/574; A61K31/506

Attorney, Agent or Firm:

TRINQUE, Brian C. (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: NUTRACEUTICAL COMPOSITIONS AND METHODS FOR USING SAME

Next Patent: METHODS OF TREATING UVEAL MELANOMA